Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-318090
Filing Date
2026-07-27
Accepted
2026-07-27 16:12:20
Documents
84
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q opk-20260630.htm   iXBRL 10-Q 4711409
2 EX-31.1 opk-ex31_1.htm EX-31.1 14651
3 EX-31.2 opk-ex31_2.htm EX-31.2 14651
4 EX-32.1 opk-ex32_1.htm EX-32.1 6602
5 EX-32.2 opk-ex32_2.htm EX-32.2 6414
  Complete submission text file 0001193125-26-318090.txt   19191520

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT opk-20260630.xsd EX-101.SCH 1836397
88 EXTRACTED XBRL INSTANCE DOCUMENT opk-20260630_htm.xml XML 4555857
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 261205862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)